Search Results - nose+and+sinus+disorders

2 Results Sort By:
Implanted Tube and External Interface for Saline or Drug Delivery to the Paranasal Sinuses
C11873: Nasal Implant for Efficient Treatment of SinusitisNovelty: Implant improves drug delivery for the treatment of sinusitis.Value Proposition: In the United States, about 3 to 10 million people suffer from chronic sinusitis, caused by inflammation of the paranasal sinus tissue. Common treatment methods include saline irrigation and steroids, used...
Published: 6/27/2024   |   Inventor(s): Marton Varady, Creighton Petty, Anastasia Borok, Lauren Kraiter, Andrew Lane
Keywords(s): Disease Indication, Drug Delivery Device, Implanted Device, Implants, Nose and Sinus Disorders, Therapeutic Devices, Therapeutics
Category(s): Technology Classifications > Medical Devices > Therapeutic Devices, Technology Classifications > Medical Devices, Clinical and Disease Specializations > Ear, Nose & Throat
VEGF Inhibition as a Therapeutic for Airway Inflammatory Disorders such as CRSwNP
UNMET NEED: A hallmark of chronic rhinosinusitis (CRS) with hyperplastic sinonasal polyposis (CRSwNP), one of the most severe forms of CRS, is the mucosal hyperplasia, resulting in chronic disease that becomes refractory to either medical or surgical management. Histological features of CRSwNP resemble that of asthmatic airways; yet, despite the significant...
Published: 6/27/2024   |   Inventor(s): Jean Kim
Keywords(s): Antibodies, Biologics, Biomarker, Chronic Rhinosinusitis, Disease Indication, Mechanism-of-action Biomarker, Nose and Sinus Disorders, Single, Targeted Therapy, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Ear, Nose & Throat, Clinical and Disease Specializations > Inflammation > Chronic Rhinosinusitis, Technology Classifications > Therapeutic Modalities > Antibodies, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Targets, Clinical and Disease Specializations > Inflammation, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum